المنشور الأصلي
Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. In 625 patients the 10-point BODE index predicted all-cause and respiratory mortality better than FEV1 alone (each one-point increase raised the hazard of death by ~34%).
New England Journal of Medicine, 2004
الإرشادات
Use post-bronchodilator FEV1 % predicted, the modified MRC dyspnoea scale, and a standardised 6-minute walk test. BODE is a prognostic and follow-up tool (e.g. lung-transplant referral discussions, pulmonary-rehabilitation response); it does not by itself set treatment.